Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
Recruiting · NCT05698212 · Registry updated 2023-01-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, disease, endometriosis, female reproductive system disorder | Recruiting | Phase 2 | 2023-01-26 | NCT05698212 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hera Biotech, Inc. | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Corpus Christi Women's Center | Corpus Christi | United States | 1 |
| University of Texas Physician's Women's Center--Memorial City | Houston | United States | 1 |
| Valley OB-GYN Clinic, PC | Saginaw | United States | 1 |